-
3
-
-
33750986529
-
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects
-
Gola M, Doga M, Bonadonna S, Mazziotti G, Vescovi PP, Giustina A 2006 Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects. Pituitary 9:221-229
-
(2006)
Pituitary
, vol.9
, pp. 221-229
-
-
Gola, M.1
Doga, M.2
Bonadonna, S.3
Mazziotti, G.4
Vescovi, P.P.5
Giustina, A.6
-
4
-
-
2642535412
-
Regulation and function of somatostatin receptors
-
Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W 2004 Regulation and function of somatostatin receptors. J Neurochem 89:1057-1091
-
(2004)
J Neurochem
, vol.89
, pp. 1057-1091
-
-
Olias, G.1
Viollet, C.2
Kusserow, H.3
Epelbaum, J.4
Meyerhof, W.5
-
5
-
-
0032780823
-
Somatostatin and its receptor family
-
Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
-
(1999)
Front Neuroendocrinol
, vol.20
, pp. 157-198
-
-
Patel, Y.C.1
-
6
-
-
0029089558
-
Somatostatin analogs: Clinical application in relation to human somatostatin receptor subtypes
-
Hofland LJ, Visser-Wisselaar HA, Lamberts SW 1995 Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 50:287-297
-
(1995)
Biochem Pharmacol
, vol.50
, pp. 287-297
-
-
Hofland, L.J.1
Visser-Wisselaar, H.A.2
Lamberts, S.W.3
-
7
-
-
0032978408
-
Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors
-
Hofland LJ, Liu Q, Van Koetsveld PM, Zuijderwijk J, Van Der HF, De Krijger RR, Schonbrunn A, Lamberts SW 1999 Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Metab 84:775-780
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 775-780
-
-
Hofland, L.J.1
Liu, Q.2
Van Koetsveld, P.M.3
Zuijderwijk, J.4
Van Der, H.F.5
De Krijger, R.R.6
Schonbrunn, A.7
Lamberts, S.W.8
-
8
-
-
0032758263
-
Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors
-
Kimura N, Pilichowska M, Date F, Kimura I, Schindler M 1999 Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res 5:3483-3487
-
(1999)
Clin Cancer Res
, vol.5
, pp. 3483-3487
-
-
Kimura, N.1
Pilichowska, M.2
Date, F.3
Kimura, I.4
Schindler, M.5
-
9
-
-
20244372692
-
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid
-
Zatelli MC, Maffei P, Piccin D, Martini C, Rea F, Rubello D, Margutti A, Culler MD, Sicolo N, degli Uberti EC 2005 Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid. J Clin Endocrinol Metab 90:2104-2109
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 2104-2109
-
-
Zatelli, M.C.1
Maffei, P.2
Piccin, D.3
Martini, C.4
Rea, F.5
Rubello, D.6
Margutti, A.7
Culler, M.D.8
Sicolo, N.9
degli Uberti, E.C.10
-
10
-
-
0036111856
-
SOM230: A novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
-
Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G 2002 SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146:707-716
-
(2002)
Eur J Endocrinol
, vol.146
, pp. 707-716
-
-
Bruns, C.1
Lewis, I.2
Briner, U.3
Meno-Tetang, G.4
Weckbecker, G.5
-
11
-
-
11144353578
-
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro
-
Hofland LJ, van der Hoek J, Van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW 2004 The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. J Clin Endocrinol Metab 89:1577-1585
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 1577-1585
-
-
Hofland, L.J.1
van der Hoek, J.2
Van Koetsveld, P.M.3
de Herder, W.W.4
Waaijers, M.5
Sprij-Mooij, D.6
Bruns, C.7
Weckbecker, G.8
Feelders, R.9
van der Lely, A.J.10
Beckers, A.11
Lamberts, S.W.12
-
12
-
-
33846111440
-
Dopamine receptor expression and function in corticotroph ectopic tumors
-
Pivonello R, Ferone D, de Herder WW, Faggiano A, Bodei L, De Krijger RR, Lombardi G, Colao A, Lamberts SW, Hofland LJ 2007 Dopamine receptor expression and function in corticotroph ectopic tumors. J Clin Endocrinol Metab 92:65-69
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 65-69
-
-
Pivonello, R.1
Ferone, D.2
de Herder, W.W.3
Faggiano, A.4
Bodei, L.5
De Krijger, R.R.6
Lombardi, G.7
Colao, A.8
Lamberts, S.W.9
Hofland, L.J.10
-
13
-
-
0023546629
-
Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995
-
Oosterom R, Verleun T, Uitterlinden P, Bruining HA, Bruining GJ, Verschoor L, Lamberts SW 1987 Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995. J Endocrinol Invest 10:547-552
-
(1987)
J Endocrinol Invest
, vol.10
, pp. 547-552
-
-
Oosterom, R.1
Verleun, T.2
Uitterlinden, P.3
Bruining, H.A.4
Bruining, G.J.5
Verschoor, L.6
Lamberts, S.W.7
-
14
-
-
0030832510
-
Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome
-
Losa M, von Werder K 1997 Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin Endocrinol (Oxf) 47:123-135
-
(1997)
Clin Endocrinol (Oxf)
, vol.47
, pp. 123-135
-
-
Losa, M.1
von Werder, K.2
-
15
-
-
0024065111
-
Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations
-
Sano T, Asa SL, Kovacs K 1988 Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-373
-
(1988)
Endocr Rev
, vol.9
, pp. 357-373
-
-
Sano, T.1
Asa, S.L.2
Kovacs, K.3
-
16
-
-
0346774833
-
Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: Case report
-
Altstadt TJ, Azzarelli B, Bevering C, Edmondson J, Nelson PB 2002 Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: case report. Neurosurgery 50:1356-1359
-
(2002)
Neurosurgery
, vol.50
, pp. 1356-1359
-
-
Altstadt, T.J.1
Azzarelli, B.2
Bevering, C.3
Edmondson, J.4
Nelson, P.B.5
-
17
-
-
0028791765
-
Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: Superiority of continuous versus intermittent administration to control hormonal secretion
-
Lefebvre S, De Paepe L, Abs R, Rahier J, Selvais P, Maiter D 1995 Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion. Eur J Endocrinol 133:320-324
-
(1995)
Eur J Endocrinol
, vol.133
, pp. 320-324
-
-
Lefebvre, S.1
De Paepe, L.2
Abs, R.3
Rahier, J.4
Selvais, P.5
Maiter, D.6
-
18
-
-
0033305296
-
Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor
-
Van den Bruel A, Fevery J, Van Dorpe J, Hofland L, Bouillon R 1999 Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor. J Clin Endocrinol Metab 84:3162-3169
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 3162-3169
-
-
Van den Bruel, A.1
Fevery, J.2
Van Dorpe, J.3
Hofland, L.4
Bouillon, R.5
-
19
-
-
0026917904
-
111In-octreotide scintigraphy in oncology
-
Krenning EP, Kwekkeboom DJ, Reubi JC, van Hagen PM, van Eijck CH, Oei HY, Lamberts SW 1992 111In-octreotide scintigraphy in oncology. Metabolism 41(9 Suppl 2):83-86
-
(1992)
Metabolism
, vol.41
, Issue.9 SUPPL. 2
, pp. 83-86
-
-
Krenning, E.P.1
Kwekkeboom, D.J.2
Reubi, J.C.3
van Hagen, P.M.4
van Eijck, C.H.5
Oei, H.Y.6
Lamberts, S.W.7
-
20
-
-
33750998202
-
Somatostatin receptor imaging for neuroendocrine tumors
-
de Herder WW, Kwekkeboom DJ, Feelders RA, van Aken MO, Lamberts SW, van der Lely AJ, Krenning EP 2006 Somatostatin receptor imaging for neuroendocrine tumors. Pituitary 9:243-248
-
(2006)
Pituitary
, vol.9
, pp. 243-248
-
-
de Herder, W.W.1
Kwekkeboom, D.J.2
Feelders, R.A.3
van Aken, M.O.4
Lamberts, S.W.5
van der Lely, A.J.6
Krenning, E.P.7
-
21
-
-
0141676019
-
Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion
-
Ren SG, Taylor J, Dong J, Yu R, Culler MD, Melmed S 2003 Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocrinol Metab 88:4239-4245
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 4239-4245
-
-
Ren, S.G.1
Taylor, J.2
Dong, J.3
Yu, R.4
Culler, M.D.5
Melmed, S.6
-
22
-
-
0038578269
-
-
Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC 2003 Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. J Clin Endocrinol Metab 88:2797-2802
-
Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC 2003 Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. J Clin Endocrinol Metab 88:2797-2802
-
-
-
-
23
-
-
2342468214
-
Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs
-
Matrone C, Pivonello R, Colao A, Cappabianca P, Cavallo LM, Del Basso De Caro ML, Taylor JE, Culler MD, Lombardi G, Di Renzo GF, Annunziato L 2004 Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs. Neuroendocrinology 79:142-148
-
(2004)
Neuroendocrinology
, vol.79
, pp. 142-148
-
-
Matrone, C.1
Pivonello, R.2
Colao, A.3
Cappabianca, P.4
Cavallo, L.M.5
Del Basso De Caro, M.L.6
Taylor, J.E.7
Culler, M.D.8
Lombardi, G.9
Di Renzo, G.F.10
Annunziato, L.11
-
24
-
-
20244376493
-
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
-
Hofland LJ, van der Hoek J, Feelders R, van Aken MO, van Koetsveld PM, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, de Herder WW, Beckers A, Lamberts SW 2005 The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. Eur J Endocrinol 152:645-654
-
(2005)
Eur J Endocrinol
, vol.152
, pp. 645-654
-
-
Hofland, L.J.1
van der Hoek, J.2
Feelders, R.3
van Aken, M.O.4
van Koetsveld, P.M.5
Waaijers, M.6
Sprij-Mooij, D.7
Bruns, C.8
Weckbecker, G.9
de Herder, W.W.10
Beckers, A.11
Lamberts, S.W.12
-
25
-
-
10744231363
-
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients
-
van der Hoek J, de Herder WW, Feelders RA, van der Lely AJ, Uitterlinden P, Boerlin V, Bruns C, Poon KW, Lewis I, Weckbecker G, Krahnke T, Hofland LJ, Lamberts SW 2004 A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients. J Clin Endocrinol Metab 89:638-645
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 638-645
-
-
van der Hoek, J.1
de Herder, W.W.2
Feelders, R.A.3
van der Lely, A.J.4
Uitterlinden, P.5
Boerlin, V.6
Bruns, C.7
Poon, K.W.8
Lewis, I.9
Weckbecker, G.10
Krahnke, T.11
Hofland, L.J.12
Lamberts, S.W.13
-
26
-
-
33751532708
-
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
-
Batista DL, Zhang X, Gejman R, Ansell PJ, Zhou Y, Johnson SA, Swearingen B, Hedley-Whyte ET, Stratakis CA, Klibanski A 2006 The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab 91:4482-4488
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4482-4488
-
-
Batista, D.L.1
Zhang, X.2
Gejman, R.3
Ansell, P.J.4
Zhou, Y.5
Johnson, S.A.6
Swearingen, B.7
Hedley-Whyte, E.T.8
Stratakis, C.A.9
Klibanski, A.10
-
27
-
-
23244458048
-
The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients
-
van der Hoek J, van der Lelij AJ, Feelders RA, de Herder WW, Uitterlinden P, Poon KW, Boerlin V, Lewis I, Krahnke T, Hofland LJ, Lamberts SW 2005 The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients. Clin Endocrinol (Oxf) 63:176-184
-
(2005)
Clin Endocrinol (Oxf)
, vol.63
, pp. 176-184
-
-
van der Hoek, J.1
van der Lelij, A.J.2
Feelders, R.A.3
de Herder, W.W.4
Uitterlinden, P.5
Poon, K.W.6
Boerlin, V.7
Lewis, I.8
Krahnke, T.9
Hofland, L.J.10
Lamberts, S.W.11
-
28
-
-
15944427116
-
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly
-
Bevan JS 2005 Clinical review: the antitumoral effects of somatostatin analog therapy in acromegaly. J Clin Endocrinol Metab 90:1856-1863
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1856-1863
-
-
Bevan, J.S.1
-
29
-
-
33750970585
-
Treatment of neuroendocrine tumors with somatostatin analogs
-
Janson ET 2006 Treatment of neuroendocrine tumors with somatostatin analogs. Pituitary 9:249-256
-
(2006)
Pituitary
, vol.9
, pp. 249-256
-
-
Janson, E.T.1
-
30
-
-
0023865612
-
Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995
-
Barkan AL, Shenker Y, Grekin RJ, Vale WW 1988 Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 61:221-226
-
(1988)
Cancer
, vol.61
, pp. 221-226
-
-
Barkan, A.L.1
Shenker, Y.2
Grekin, R.J.3
Vale, W.W.4
-
31
-
-
0030612281
-
Molecular pharmacology of somatostatin receptor subtypes
-
Patel YC 1997 Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 20:348-367
-
(1997)
J Endocrinol Invest
, vol.20
, pp. 348-367
-
-
Patel, Y.C.1
-
32
-
-
0036031864
-
Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line
-
Zatelli MC, Tagliati F, Piccin D, Taylor JE, Culler MD, Bondanelli M, degli Uberti EC 2002 Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. Biochem Biophys Res Commun 297:828-834
-
(2002)
Biochem Biophys Res Commun
, vol.297
, pp. 828-834
-
-
Zatelli, M.C.1
Tagliati, F.2
Piccin, D.3
Taylor, J.E.4
Culler, M.D.5
Bondanelli, M.6
degli Uberti, E.C.7
|